USA – Visura, a Minneapolis, MN-based medical device company, raised $4M in Series B funding.
The funding is led by a strategic investor with participation from both new and existing investors.The company intends to use the funds to support the commercialization of its TEECAD® System.Founded in 2015 by David Marmor, MD, and led by Christine Horton, president and CEO, Visura is a medical device company dedicated to delivering visualization solutions to improve the quality of transesophageal echocardiogram probe intubations. The company has developed the TEECAD System, an FDA-cleared, disposable camera that connects to a TEE probe, providing physicians real-time visualization for more efficient and effective probe placement.In addition to securing Series B funding, Visura recently received a Launch Minnesota Innovation Grant issued by the Minnesota Department of Employment and Economic Development. To bring the technology to heart centers across the U.S., the company also launched a new product update in 2022, expanding the usage of the TEECAD System to include the Philips X8-2t Transducer.18/01/2023
